Jasmin Hong - Haw ParLimited Executive
| HAWPF Stock | USD 7.12 0.00 0.00% |
Executive
Ms. Jasmin Hong General Manager Marketing of Haw Par Healthcare Limited, a subsidiary of Haw Par Corporation Limited. She joined Haw Par Healthcare in 2004 as Deputy General Manager . Promoted to current position in 2014. Holds a Bachelor of Commerce degree from the University of Melbourne. since 2014.
| Tenure | 10 years |
| Phone | 65 6337 9102 |
| Web | https://www.hawpar.com |
Haw ParLimited Management Efficiency
Haw ParLimited's management efficiency ratios could be used to measure how well Haw ParLimited manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Andrin Oswald | Novartis AG ADR | 41 | |
| William Winters | Novartis AG ADR | 60 | |
| Timothy Schmid | Johnson Johnson | 54 | |
| Michael Varney | Roche Holding Ltd | 60 | |
| John Reed | Roche Holding Ltd | 59 | |
| Charlotte PamerWieser | Novartis AG ADR | N/A | |
| Bertrand Bodson | Novartis AG ADR | 44 | |
| Eric Dozier | Eli Lilly and | 56 | |
| David MD | Eli Lilly and | N/A | |
| Peter Dannenbaum | Merck Company | N/A | |
| Steven Baert | Novartis AG ADR | 45 | |
| Joerg Koglin | Merck Company | N/A | |
| Charles Sawyers | Novartis AG ADR | 62 | |
| Guy MD | Johnson Johnson | N/A | |
| Karl Mahler | Roche Holding Ltd | N/A | |
| Susan MD | AstraZeneca PLC ADR | 58 | |
| Jim Greffet | Eli Lilly and | N/A | |
| Urs Jaisli | Roche Holding Ltd | 62 | |
| Erwin Vanhaecke | Novartis AG ADR | N/A | |
| Alan Hippe | Roche Holding Ltd | 56 | |
| Tom Cavanaugh | Johnson Johnson | N/A | |
Management Performance
| Return On Equity | 0.0424 | |||
| Return On Asset | 0.0063 |
Haw ParLimited Leadership Team
Elected by the shareholders, the Haw ParLimited's board of directors comprises two types of representatives: Haw ParLimited inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Haw. The board's role is to monitor Haw ParLimited's management team and ensure that shareholders' interests are well served. Haw ParLimited's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Haw ParLimited's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sat Khattar, Independent Director | ||
| Siew Shiu, Acting Group Internal Audit Manager | ||
| Meng Kwek, Regional General Manager of Underwater World Singapore Pte Ltd / Haw Par Leisure Pte Ltd | ||
| Swee Sim, Non-Executive Independent Director | ||
| Cho Wee, Non-Executive, Non Independent Chairman of the Board | ||
| Chua Keeth, Deputy General Manager - Marketing of Haw Par Healthcare Limited | ||
| Wah Ng, Deputy General Manager-Manufacturing of Healthcare | ||
| Ee Wee, CEO and President Director, Member of Investment Committee, CEO of Haw Par Healthcare Limited and Acting President of Haw Par Healthcare Limited | ||
| Mui Kow, Senior Manager-Quality & Regulatory Affairs of Healthcare | ||
| Brian Loo, Group Mang | ||
| Peter Chew, Deputy General Manager of Underwater World Singapore Pte Ltd | ||
| Kia Chew, Non-Executive Independent Director | ||
| Choon Chew, Non-Executive Independent Director | ||
| Tang Lee, Mang Communications | ||
| Tang Chow, Human Director | ||
| Anthony Chang, Curator of Underwater World Singapore Pte Ltd | ||
| Suan Lee, Non-Executive Independent Director | ||
| Kun Chiew, Group Sec | ||
| Ah Han, Executive Director, Member of Investment Committee, General Manager of Haw Par Healthcare Limited and Director of Haw Par Healthcare Limited | ||
| Hiang Gn, Non-Executive Independent Director | ||
| Seok Lim, CFO and Company Secretary | ||
| Sien Tarn, General Manager - Corporate Development & Property Division | ||
| Sung Whang, General Manager of Underwater World Pattaya Ltd | ||
| Soo Hwang, Non-Executive Independent Director | ||
| Bee Goh, Director & General Manager - Manufacturing of Haw Par Healthcare Limited | ||
| Say Chow, Group Finance Controller | ||
| Jasmin Hong, Deputy General Manager - Marketing of Haw Par Healthcare Limited | ||
| Kay Lee, Company Secretary | ||
| EeChao Wee, Non-Executive Deputy Chairman of the Board |
Haw Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Haw ParLimited a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0424 | |||
| Return On Asset | 0.0063 | |||
| Profit Margin | 0.79 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | (701.58 M) | |||
| Shares Outstanding | 221.37 M | |||
| Shares Owned By Insiders | 36.98 % | |||
| Shares Owned By Institutions | 32.30 % | |||
| Price To Earning | 15.92 X | |||
| Price To Book | 0.65 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Haw Par. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Haw Pink Sheet analysis
When running Haw ParLimited's price analysis, check to measure Haw ParLimited's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haw ParLimited is operating at the current time. Most of Haw ParLimited's value examination focuses on studying past and present price action to predict the probability of Haw ParLimited's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haw ParLimited's price. Additionally, you may evaluate how the addition of Haw ParLimited to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |